{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:57Z","timestamp":1790713197843,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1124\/jpet.120.000109","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T20:55:12Z","timestamp":1595883312000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia"],"prefix":"10.1016","volume":"375","author":[{"given":"Fernando","family":"Carre\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vict\u00f3ria Eteges","family":"Helfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keli Jaqueline","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Bem","family":"Olivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Paese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola Schons","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Stanis\u00e7uaski","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela Mari","family":"Kuze Rates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-8658","authenticated-orcid":false,"given":"I\u00f1aki","family":"Troc\u00f3niz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-2991","authenticated-orcid":false,"given":"Teresa","family":"Dalla Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000109_bib1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jpba.2008.02.025","article-title":"Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug","volume":"47","author":"Ara\u00fajo","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.120.000109_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","article-title":"In vitro P-glycoprotein affinity for atypical and conventional antipsychotics","volume":"71","author":"Boulton","year":"2002","journal-title":"Life Sci"},{"key":"10.1124\/jpet.120.000109_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2020.01.007","article-title":"Quetiapine lipid core nanocapsules restore prepulse inhibition deficits in a neurodevelopmental model of schizophrenia in male and female rats","volume":"218","author":"Carre\u00f1o","year":"2020","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.120.000109_bib4","first-page":"1181","article-title":"Characterizing the mechanism of quetiapine distribution in lipid-core nanocapsules pseudo-phases using a validated LC\/UV method","volume":"38","author":"Carre\u00f1o","year":"2015","journal-title":"Quim Nova"},{"key":"10.1124\/jpet.120.000109_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpba.2015.11.027","article-title":"Pre-clinical investigation of the modulation of quetiapine plasma pharmacokinetics and tissues biodistribution by lipid-core nanocapsules","volume":"119","author":"Carre\u00f1o","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.120.000109_bib6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1021\/acs.molpharmaceut.5b00875","article-title":"Pharmacokinetic investigation of quetiapine transport across blood\u2013brain barrier mediated by lipid core nanocapsules using brain microdialysis in rats","volume":"13","author":"Carre\u00f1o","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.120.000109_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2006.01.035","article-title":"Diffusion and mathematical modeling of release profiles from nanocarriers","volume":"313","author":"Cruz","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.120.000109_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pscychresns.2010.05.002","article-title":"Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function","volume":"183","author":"de Klerk","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1124\/jpet.120.000109_bib9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1166\/jbn.2015.2082","article-title":"Nanoencapsulation improves relative bioavailability and antipsychotic effect of olanzapine in rats","volume":"11","author":"Dimer","year":"2015","journal-title":"J Biomed Nanotechnol"},{"key":"10.1124\/jpet.120.000109_bib10","doi-asserted-by":"crossref","first-page":"e00013","DOI":"10.1002\/psp4.13","article-title":"Physiologically based pharmacokinetic modeling of fluorescently labeled block copolymer nanoparticles for controlled drug delivery in leukemia therapy","volume":"4","author":"Gilkey","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/jpet.120.000109_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pnpbp.2012.07.010","article-title":"Gender differences in cognitive function of patients with chronic schizophrenia","volume":"39","author":"Han","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.120.000109_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells7040024","article-title":"Towards improvements for penetrating the blood-brain barrier-recent progress from a material and pharmaceutical perspective","volume":"7","author":"He","year":"2018","journal-title":"Cells"},{"key":"10.1124\/jpet.120.000109_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1166\/jbn.2009.1004","article-title":"Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area","volume":"5","author":"J\u00e4ger","year":"2009","journal-title":"J Biomed Nanotechnol"},{"key":"10.1124\/jpet.120.000109_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose--an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1124\/jpet.120.000109_bib15","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/jpet.120.000109_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/jpet.120.000109_bib17","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1021\/nn1018818","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"4","author":"Li","year":"2010","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.120.000109_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1208\/s12248-016-0010-3","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of pharmaceutical nanoparticles","volume":"19","author":"Li","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/jpet.120.000109_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM [published correction appears in Comput Methods Programs Biomed (2005) 80:277]","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1124\/jpet.120.000109_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2016.07.003","article-title":"Pharmacokinetic considerations of nanodelivery to the brain: using modeling and simulations to predict the outcome of liposomal formulations","volume":"92","author":"Lindqvist","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.120.000109_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/mp300272a","article-title":"Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study","volume":"10","author":"Lindqvist","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.120.000109_bibib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1124\/jpet.120.000109_bib22","series-title":"Paxinos and Watson\u2019s The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2014"},{"key":"10.1124\/jpet.120.000109_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2004.09.053","article-title":"The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex","volume":"504","author":"Pira","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.120.000109_bib24","first-page":"492","article-title":"Breeding and housing laboratory rats and mice in the same room does not affect the growth or reproduction of either species","volume":"48","author":"Pritchett-Corning","year":"2009","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1124\/jpet.120.000109_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1166\/jbn.2016.2215","article-title":"Lipid-core nanocapsules act as a drug shuttle through the blood brain barrier and reduce glioblastoma after intravenous or oral administration","volume":"12","author":"Rodrigues","year":"2016","journal-title":"J Biomed Nanotechnol"},{"key":"10.1124\/jpet.120.000109_bib26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1023\/B:PHAM.0000041468.00587.c6","article-title":"An integrated model for the analysis of pharmacokinetic data from microdialysis experiments","volume":"21","author":"Tunblad","year":"2004","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.120.000109_bib27","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1208\/ps040427","article-title":"Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis","volume":"4","author":"W\u00e4hlby","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1124\/jpet.120.000109_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-009-1601-9","article-title":"Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex","volume":"206","author":"Yamamura","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.120.000109_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.xphs.2018.10.037","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"108","author":"Yuan","year":"2019","journal-title":"J Pharm Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:44:06Z","timestamp":1739965446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0022356524270087"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000109","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}